Abstract |
Purpose: The present study was designed to screen the genetic polymorphisms and expression profiling of CEP-152 and CEP-63 genes in brain tumor patients. Methods: The amplification refractory mutation system PCR technique (ARMS-PCR) was used for mutation analysis using 300 blood samples of brain tumor patients and 300 overtly healthy controls. For expression analysis, 150 brain tumor tissue samples along with adjacent uninvolved/normal tissues (controls) were collected. Results: A significantly higher frequency of the mutant genotype of the CEP-152 single nucleotide polymorphism (rs2169757) and CEP-63 single nucleotide polymorphisms (rs9809619 and rs13060247) was observed in patients versus overtly healthy controls. The authors' results showed highly significant deregulation of CEP-152 (p < 0.0001) and CEP-63 (p < 0.0001) in glioma/ meningioma tumor tissues versus adjacent normal tissue. Conclusion: The present study showed that variations in CEP-152 and CEP-63 genes were associated with an increased risk of brain tumor.
|
Authors | Ishrat Mahjabeen, Yusra Maqsood, Ramsha Abbasi, Malik Waqar Ahmed, Mahmood Akhtar Kayani |
Journal | Future oncology (London, England)
(Future Oncol)
Vol. 17
Issue 25
Pg. 3355-3372
(Sep 2021)
ISSN: 1744-8301 [Electronic] England |
PMID | 34156311
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- 3' Untranslated Regions
- CEP152 protein, human
- CEP63 protein, human
- Cell Cycle Proteins
- MicroRNAs
|
Topics |
- 3' Untranslated Regions
(genetics)
- Adult
- Brain
(pathology, surgery)
- Brain Neoplasms
(blood, epidemiology, genetics, surgery)
- Carcinogenesis
(genetics)
- Case-Control Studies
- Cell Cycle Proteins
(genetics)
- DNA Mutational Analysis
- Female
- Follow-Up Studies
- Gene Expression Regulation, Neoplastic
- Genetic Predisposition to Disease
- Glioma
(blood, epidemiology, genetics, surgery)
- Humans
- Male
- MicroRNAs
(metabolism)
- Polymorphism, Single Nucleotide
- Risk Assessment
(methods, statistics & numerical data)
|